Carmela Passaro
Harvard University
H-index: 19
North America-United States
Top articles of Carmela Passaro
Abstract LB065: Tumor-infiltrating lymphocytes (TIL) engineered with regulatable membrane-bound IL15 (mbIL15) and LIGHT (TNFSF14) show enhanced efficacy in fibroblast …
Cancer Research
2024/4/5
Carmela Passaro
H-Index: 13
Abstract LB093: Engineering tumor infiltrating lymphocytes from sarcoma and colorectal tumors with membrane bound IL-15 for IL-2 independent expansion and enhanced cytotoxicity …
Cancer Research
2023/4/14
Enhancers of innate and adaptive immunity combine with membrane bound IL15 to increase the efficacy of tumor infiltrating lymphocyte (TIL) therapy for tumors with …
J. Immunother. Cancer https://doi. org/10.1136/jitc-2022-sitc2022
2022/11/1
In Vivo Delivery of a CD20 CAR Using a CD8-Targeted Fusosome in Southern Pig-Tail Macaques (M. nemestrina) Results in B Cell Depletion
Blood
2021/11/23
Abstract LB105: In vivo CAR T therapy: targeted in vivo gene delivery of a CAR using a CD8-specific fusogen results in tumor eradication
Cancer Research
2021/7/1
Akinola Emmanuel
H-Index: 6
Carmela Passaro
H-Index: 13
Paige Baldwin
H-Index: 6
Anna Liang
H-Index: 1
Albert Ruzo
H-Index: 20
Oncolytic virus therapy alters the secretome of targeted glioblastoma cells
Cancers
2021/3/14
Carmela Passaro
H-Index: 13
Hiroshi Nakashima
H-Index: 16
Tumor interferon signaling is regulated by a lncRNA INCR1 transcribed from the PD-L1 locus
Molecular Cell
2020/6/5
Glioblastoma infiltration of both tumor-and virus-antigen specific cytotoxic T cells correlates with experimental virotherapy responses
Scientific reports
2020/3/20
Carmela Passaro
H-Index: 13
Mykola Zdioruk
H-Index: 7
Xiaoli Zhang
H-Index: 1
Hiroshi Nakashima
H-Index: 16
Correction: arming an oncolytic herpes simplex virus type 1 with a single-chain fragment variable antibody against PD-1 for experimental glioblastoma therapy
Clinical Cancer Research
2020/2/1
